Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.23 USD | -0.24% | -0.83% | +208.89% |
May. 15 | Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Valerie Morisset
FOU | Founder | 55 | 18-10-17 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-17 |
Emily Pimblett
AUD | Comptroller/Controller/Auditor | 40 | 21-02-28 |
Joanne Palmer
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Liam Ratcliffe
BRD | Director/Board Member | 60 | 19-09-30 |
Adam Rosenberg
BRD | Director/Board Member | 54 | 20-09-30 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-17 |
Simon Tate
BRD | Director/Board Member | 58 | 19-01-31 |
Judith Dunn
BRD | Director/Board Member | 62 | 21-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,091,166 | 21,766,139 ( 74.82 %) | 0 | 74.82 % |
Company contact information
Eliem Therapeutics, Inc.
2801 Centerville Road 1st Floor
19808-1609, Wilmington
+
http://www.eliemtx.comSector
1st Jan change | Capi. | |
---|---|---|
+201.78% | 231M | |
+9.91% | 115B | |
+11.72% | 106B | |
-2.59% | 21.96B | |
-12.93% | 21.87B | |
-5.29% | 19.21B | |
-3.84% | 18.08B | |
-38.57% | 17.71B | |
+7.22% | 14.32B | |
+35.40% | 12.42B |
- Stock Market
- Equities
- ELYM Stock
- Company Eliem Therapeutics, Inc.